Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 9
Original Research
Regorafenib Combined with PD-1 Blockade Immunotherapy versus Regorafenib as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,044 | Dovepress* | 6,217+ | 407 | 6,624 | |
| PubMed Central* | 827 | 403 | 1,230 | ||
| Totals | 7,044 | 810 | 7,854 | ||
| *Since 10 March 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar